Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd — Class II drug recall D-1153-2018
Terminated recall by Pharmcore Inc., reported 2018-09-05, distributed nationwide. Lack of assurance of sterility.
| Recall number | D-1153-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pharmcore Inc., Hallandale Beach, FL, United States |
| Recall initiated | 2018-08-02 |
| Classified | 2018-08-28 |
| Reported by FDA | 2018-09-05 |
| Terminated | 2022-01-18 |
| Distributed | Nationwide (US) |
| Quantity | 6 vials |
| Reason classes | sterility |
| Lot numbers | IPA3-17 |
| Expiration dates | 2018-07 |
Product
Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Reason for recall
Lack of assurance of sterility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1153-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.